Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT04312594 · COMPLETED
Trial details
- NCT number
- NCT04312594
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2022-06-09
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.